Vertex Pharmaceuticals Sets Q4 2025 Earnings Release Date, Stock Fluctuates
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 22 2026
0mins
Source: Benzinga
- Stock Fluctuation: Vertex Pharmaceuticals saw its stock rise by 4.31% to $461.14 on Wednesday, but it dipped 0.21% to $460.16 in after-hours trading, indicating market volatility despite an overall upward trend.
- Earnings Release Schedule: The company announced it will release its Q4 and full-year 2025 financial results on February 12 after market close, with projected earnings per share of $4.85 and quarterly revenue of $3.17 billion, reflecting sustained profitability and growth potential.
- Insider Stock Purchases: Directors Bruce I. Sachs and Suketu Upadhyay acquired deferred stock units on January 15, with Sachs purchasing 107.088 units valued at approximately $47,499 and Upadhyay acquiring 80.316 units valued at nearly $35,624, demonstrating executive confidence in the company's future.
- Analyst Rating Optimism: Recent analyst upgrades for Vertex include Bernstein and Wolfe Research raising their ratings to Outperform with price targets of $548 and $535, respectively, indicating strong market expectations for the company's future performance.
Get Free Real-Time Notifications for Any Stock
Monitor tickers like EQH with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
Analyst Views on EQH
Wall Street analysts forecast EQH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EQH is 61.43 USD with a low forecast of 58.00 USD and a high forecast of 66.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Analyst Rating
6 Buy
1 Hold
0 Sell
Strong Buy
Current: 46.110
Low
58.00
Averages
61.43
High
66.00
Current: 46.110
Low
58.00
Averages
61.43
High
66.00
About EQH
Equitable Holdings, Inc. is a financial services holding company, which consists of complementary businesses, such as Equitable, AllianceBernstein and Equitable Advisors. Its segments include Retirement, Asset Management, and Wealth Management. Retirement segment provides retirement solutions to individual and institutional clients, including individual and group annuities, retirement savings plans, and institutional savings products. Asset Management segment provides diversified investment management and related services globally to a range of clients through three main client channels: Institutional, Retail and Private Wealth. Wealth Management segment offers discretionary and non-discretionary investment advisory accounts, financial planning and advice, life insurance, and annuity products. Equitable provides retirement and protection strategies to individuals, families and businesses. AllianceBernstein is an investment management firm that offers diversified investment services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Vertex Pharmaceuticals Sets Q4 2025 Earnings Release Date, Stock Fluctuates
- Stock Fluctuation: Vertex Pharmaceuticals saw its stock rise by 4.31% to $461.14 on Wednesday, but it dipped 0.21% to $460.16 in after-hours trading, indicating market volatility despite an overall upward trend.
- Earnings Release Schedule: The company announced it will release its Q4 and full-year 2025 financial results on February 12 after market close, with projected earnings per share of $4.85 and quarterly revenue of $3.17 billion, reflecting sustained profitability and growth potential.
- Insider Stock Purchases: Directors Bruce I. Sachs and Suketu Upadhyay acquired deferred stock units on January 15, with Sachs purchasing 107.088 units valued at approximately $47,499 and Upadhyay acquiring 80.316 units valued at nearly $35,624, demonstrating executive confidence in the company's future.
- Analyst Rating Optimism: Recent analyst upgrades for Vertex include Bernstein and Wolfe Research raising their ratings to Outperform with price targets of $548 and $535, respectively, indicating strong market expectations for the company's future performance.
Continue Reading
eQ Plc Appoints Taina Kyllönen as Chief People and Communications Officer, Granted 40,000 Stock Options
- Executive Appointment: eQ Plc announced on November 19, 2025, the appointment of Taina Kyllönen as Chief People and Communications Officer, highlighting the company's strategic focus on talent management and communication.
- Options Grant: Kyllönen officially assumed her role on January 19, 2026, receiving 40,000 stock options linked to her position, aimed at aligning executive incentives with company performance.
- Transaction Details: The stock option transaction has a unit price of €0, with a total volume of 40,000 shares, reflecting the company's commitment to transparency and compliance in its executive incentive mechanisms.
- Asset Management Context: eQ Group manages approximately €13.7 billion in assets, encompassing asset management and corporate finance services, demonstrating the company's robust position and growth potential in the financial market.
Continue Reading